title: Residual antigenicity and its management after removal of vascularized grafts.
authors.affiliation: Department of Surgery, Toranomon Hospital, Tokyo, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Harihara
authors.forename: K
authors.initials: K
authors.lastname: Sanjo
authors.forename: O
authors.initials: O
authors.lastname: Otsubo
authors.forename: G
authors.initials: G
authors.lastname: Watanabe
authors.forename: M
authors.initials: M
authors.lastname: Tsurumaru
authors.forename: Y
authors.initials: Y
authors.lastname: Idezuki
mesh_terms: D000818:Animals; D003326:Coronary Circulation; D016572:Cyclosporine / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D006085:Graft Survival / Q000276:immunology*; D016027:Heart Transplantation / Q000276:immunology*; D008297:Male; D051381:Rats; D011917:Rats, Inbred Lew; D011919:Rats, Inbred Strains; D016038:Skin Transplantation / Q000276:immunology*; D014183:Transplantation, Heterologous; D014184:Transplantation, Homologous
chemical_list: D016572:Cyclosporine